Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport System
New System Will Lead to Drastic Reduction in Laboratory Supply Costs
WEST PALM BEACH, FL -- (Marketwired) -- 01/28/16 -- Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), which owns and operates a diverse family of healthcare companies, received a trademark from the United States Patent and Trademark Office for StableSpot®, a clinical dry specimen transport kit for collection, stabilization, and transport of urine, serum, plasma, and blood. This innovative new approach will provide convenient sample collection for a patient, help protect the integrity of samples, cut down on packing and shipping concerns, and reduce total laboratory supply costs.
"One of the greatest challenges to providing a diagnostic service directly to an individual is the collection, transport and maintaining the stability of specimens," remarked Seamus Lagan, CEO of Rennova Health, Inc. "StableSpot® provides a viable solution to an area in our business that has historically been complicated and costly."
As well as the inconvenient traditional collection methods, many laboratory specimens require stabilization, refrigeration, and/or freezing in order to maintain specimen stability during transit. To mitigate against specimen degradation, shipments would contain ice packs, coolers, and other special shipping equipment. Now, StableSpot's technology allows dry specimens to take the place of liquid ones.
StableSpot® Dry-Specimen Collection Kits will be used by Rennova Health, Inc., at their five clinical reference laboratories nationwide. For more information about StableSpot® and Rennova Health, please contact Sebastien Sainsbury at (561) 666-9818 or ssainsbury@rennovahealth.com.
About Rennova Health, Inc.
Rennova Health, Inc. (NASDAQ: RNVA) provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcome. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information about Rennova Health, Inc., visit www.rennovahealth.com.
Contacts
Rennova Health Media Contact:
Sebastien Sainsbury
(561) 666-9818
Email Contact
Investors:
LHA
Kim Golodetz
(212) 838-3777
Email Contact
Or
Bruce Voss
(310) 691-7100
Email Contact
Source: Rennova Health, Inc.
Released January 28, 2016